PROFUSA, INC. Increase (Decrease) in Accounts Payable, Trade
PROFUSA, INC. (PFSA) reported Increase (Decrease) in Accounts Payable, Trade of $1.06 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2025-08-14
- PROFUSA, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-06-30 was $810.67K, a 795.33% increase year-over-year.
- PROFUSA, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-03-31 was $249.39K, a 50.99% increase year-over-year.
- PROFUSA, INC. increase (decrease) in accounts payable, trade for the quarter ending 2024-06-30 was $90.54K.
- PROFUSA, INC. increase (decrease) in accounts payable, trade for the quarter ending 2024-03-31 was $165.17K.
- PROFUSA, INC. increase (decrease) in accounts payable, trade for fiscal 2024 was $235.37K, a 37024.45% increase from fiscal 2023.
- PROFUSA, INC. increase (decrease) in accounts payable, trade for fiscal 2023 was $634.00.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|
| 2025-06-30 | $810.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.06M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $249.39K 10-Q · filed 2025-06-13 | ||
| 2024-12-31 | $235.37K 10-K · filed 2025-03-31 | ||
| 2024-06-30 | $90.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $255.72K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $165.17K 10-Q · filed 2025-06-13 | ||
| 2023-12-31 | $634.00 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |